中国伤残医学Issue(3)：32-33,2.DOI:10.13214/j.cnki.cjotadm.2015.03.021
重组人心钠肽治疗急性心力衰竭的临床研究
Clinical Study of Recombinant Human atrial Natriuretic Peptide in Treatment of Acute Heart Failure
摘要
Abstract
Objective:To investigate the recombinant human atrial natriuretic peptide in treatment of acute heart failure efficacy .Meth-ods:the application of recombinant human atrial natriuretic peptide in patients with acute heart failure treatment since 2011 May to 2013 February in our hospital , in hemodynamic parameters monitoring of patients before and after treatment .Results:of the 66 patients, 59 ca-ses of remission, 27 cases markedly effective, effective 32 cases, invalid 7 cases, efficiency of 89.39%.Conclusion:recombinant human atrial natriuretic peptide drugs and reliable effect in the treatment of acute heart failure , high safety.关键词
急性心力衰竭/疗效/重组人心钠肽/血流动力学Key words
Acute heart failure/Curative effect/Recombinant human atrial natriuretic peptide/Hemodynamics分类
医药卫生引用本文复制引用
贺宇峰..重组人心钠肽治疗急性心力衰竭的临床研究[J].中国伤残医学,2015,(3):32-33,2.
